Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Xylem (XYL)

Xylem Q3 revenue rises 8% to $2.3 billion and raises 2025 guidance

Positive Impact 4 of 5 earnings Written later

Xylem reported third-quarter 2025 revenue of $2.3 billion, up 8% on a reported basis and 7% organically, and reported diluted EPS of $0.93, up 4%. Adjusted EPS rose 23% to $1.37, and the company raised its full-year 2025 revenue and adjusted EPS guidance, which matters to shareholders because it reflects higher expected earnings for the year.

Key points

  • Q3 2025 revenue was $2.3 billion, up 8% reported and 7% organic; net income attributable to Xylem was $227 million
  • Q3 2025 EPS was $0.93 reported, up 4%, and $1.37 adjusted, up 23% from $1.11
  • Full-year 2025 revenue guidance is about $9.0 billion, up 5% to 6% reported versus 4% to 5% previously
  • Full-year 2025 adjusted EPS guidance is $5.03 to $5.08, up from the previous $4.70 to $4.85

The filing

CompanyXylem (XYL)
Form8-K, current report
Filed with the SECOct 28, 2025, 7:03 AM ET
Accession number0001524472-25-000043

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:42 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 28, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.